Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...

Takara Bio USA collaborates with Illumina on a single-cell-resolution spatial mapping workflow, presented at AGBT 2026.

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

Advances in 3D spatial multiomics are changing how researchers study tissue architecture. We spoke with Stellaromics' CEO, Dr. Todd Dickinson, to learn how this approach preserves structure and ...

In this piece, I highlight one particular talk that caught my interest — given by Elana Fertig, Dean E. Albert Reece Endowed ...

A new spatial transcriptomic technology captures RNA patterns without requiring expensive imaging ...

IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' spatial context.

Stellaromics today launched Pyxatm, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch marks a ...

SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- OmicInsight Corporation, an innovator in ...